Skip to content

Tag Archives: After

Neumedicines Receives $2.5 Million from HHS/BARDA After Successful Non-Human Primate Studies to Further Advance HemaMax as a Radiation Countermeasure

Pasadena, CA (PRWEB) August 16, 2010 Neumedicines Inc. today announced that the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (DHHS) exercised the third milestone-based option on the Company’s existing contract with BARDA to develop Neumedicines’ lead therapeutic, HemaMax™, as a treatment for acute radiation exposure. The [...]

Hot Cheerleader Hoax: Disorder After Flu Shot? (Video)

TYT Network (new WTF?! channel): www.youtube.com Join the TYT Facebook Fan Page: tinyurl.com Follow TYT on Twitter: twitter.com Follow TYT on Google Buzz: www.google.com Check Out TYT Interviews www.youtube.com Watch more at www.theyoungturks.com